JP2023504115A5 - - Google Patents
Info
- Publication number
- JP2023504115A5 JP2023504115A5 JP2022531531A JP2022531531A JP2023504115A5 JP 2023504115 A5 JP2023504115 A5 JP 2023504115A5 JP 2022531531 A JP2022531531 A JP 2022531531A JP 2022531531 A JP2022531531 A JP 2022531531A JP 2023504115 A5 JP2023504115 A5 JP 2023504115A5
- Authority
- JP
- Japan
- Prior art keywords
- agent according
- approximately
- tadalafil
- selexipag
- macitentan
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024118344A JP7620758B2 (ja) | 2019-11-29 | 2024-07-24 | 肺動脈性肺高血圧症の治療方法 |
| JP2025127467A JP2025172745A (ja) | 2019-11-29 | 2025-07-30 | 肺動脈性肺高血圧症の治療方法 |
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962941910P | 2019-11-29 | 2019-11-29 | |
| US62/941,910 | 2019-11-29 | ||
| US202063023452P | 2020-05-12 | 2020-05-12 | |
| US63/023,452 | 2020-05-12 | ||
| US202063076149P | 2020-09-09 | 2020-09-09 | |
| US63/076,149 | 2020-09-09 | ||
| PCT/EP2020/083593 WO2021105331A1 (en) | 2019-11-29 | 2020-11-27 | Methods of treating pulmonary arterial hypertension |
Related Child Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024118344A Division JP7620758B2 (ja) | 2019-11-29 | 2024-07-24 | 肺動脈性肺高血圧症の治療方法 |
| JP2025127467A Division JP2025172745A (ja) | 2019-11-29 | 2025-07-30 | 肺動脈性肺高血圧症の治療方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023504115A JP2023504115A (ja) | 2023-02-01 |
| JP2023504115A5 true JP2023504115A5 (https=) | 2023-12-04 |
| JP7721520B2 JP7721520B2 (ja) | 2025-08-12 |
Family
ID=73726769
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022531531A Active JP7721520B2 (ja) | 2019-11-29 | 2020-11-27 | 肺動脈性肺高血圧症の治療方法 |
| JP2024118344A Active JP7620758B2 (ja) | 2019-11-29 | 2024-07-24 | 肺動脈性肺高血圧症の治療方法 |
| JP2025127467A Pending JP2025172745A (ja) | 2019-11-29 | 2025-07-30 | 肺動脈性肺高血圧症の治療方法 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024118344A Active JP7620758B2 (ja) | 2019-11-29 | 2024-07-24 | 肺動脈性肺高血圧症の治療方法 |
| JP2025127467A Pending JP2025172745A (ja) | 2019-11-29 | 2025-07-30 | 肺動脈性肺高血圧症の治療方法 |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US12485119B2 (https=) |
| EP (1) | EP4065119B1 (https=) |
| JP (3) | JP7721520B2 (https=) |
| KR (1) | KR20220106974A (https=) |
| CN (1) | CN114728002A (https=) |
| AU (1) | AU2020392424A1 (https=) |
| BR (1) | BR112022010311A2 (https=) |
| CA (1) | CA3158292A1 (https=) |
| CR (1) | CR20220305A (https=) |
| EC (1) | ECSP22051163A (https=) |
| ES (1) | ES2994089T3 (https=) |
| IL (1) | IL293271A (https=) |
| JO (1) | JOP20220127A1 (https=) |
| MX (1) | MX2022006403A (https=) |
| PE (1) | PE20221320A1 (https=) |
| PH (1) | PH12022551294A1 (https=) |
| TW (1) | TW202133851A (https=) |
| WO (1) | WO2021105331A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2024099953A1 (en) * | 2022-11-07 | 2024-05-16 | Actelion Pharmaceuticals Ltd | Combination of macitentan and tadalafil for the treatment of pulmonary arterial hypertension |
| KR102663470B1 (ko) * | 2023-03-16 | 2024-05-10 | 주식회사 케어사이드 | 폐성 고혈압에 의한 심장 질환 예방 및 심장 치료용 조성물 및 이를 포함하는 기능성 제제 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2002227984B8 (en) | 2000-12-18 | 2007-01-04 | Actelion Pharmaceuticals Ltd. | Novel sulfamides and their use as endothelin receptor antagonists |
| TWI316055B (https=) | 2001-04-26 | 2009-10-21 | Nippon Shinyaku Co Ltd | |
| US20050101608A1 (en) * | 2003-09-24 | 2005-05-12 | Santel Donald J. | Iloprost in combination therapies for the treatment of pulmonary arterial hypertension |
| WO2007031933A2 (en) | 2005-09-12 | 2007-03-22 | Actelion Pharmaceuticals Ltd | Stable pharmaceutical composition comprising a pyrimidine-sulfamide |
| AR062501A1 (es) | 2006-08-29 | 2008-11-12 | Actelion Pharmaceuticals Ltd | Composiciones terapeuticas |
| JP5764061B2 (ja) | 2008-08-13 | 2015-08-12 | アクテリオン ファーマシューティカルズ リミテッドＡｃｔｅｌｉｏｎ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ Ｌｔｄ | マシテンタン含有治療用組成物 |
| LT2447254T (lt) | 2009-06-26 | 2018-01-10 | Nippon Shinyaku Co., Ltd. | Kristalai |
| WO2011024874A1 (ja) | 2009-08-26 | 2011-03-03 | 日本新薬株式会社 | 塩基付加塩 |
| MX346730B (es) | 2010-10-15 | 2017-03-30 | Gilead Sciences Inc | Composiciones y metodos para el tratamiento de la hipertension pulmonar. |
| EP3136101B1 (en) | 2014-04-22 | 2019-12-25 | Tohoku University | Method of testing for pulmonary hypertension |
| CN107427698A (zh) | 2015-01-13 | 2017-12-01 | 维瓦斯公司 | 肺高血压的组合疗法 |
| CA3041679A1 (en) | 2016-10-27 | 2018-05-03 | Lawrence S. ZISMAN | Combination therapy for treating pulmonary hypertension |
| PT3897646T (pt) * | 2018-12-21 | 2024-07-08 | Actelion Pharmaceuticals Ltd | Macitentano para tratamento de hipertensão arterial pulmonar |
-
2020
- 2020-11-27 CA CA3158292A patent/CA3158292A1/en active Pending
- 2020-11-27 AU AU2020392424A patent/AU2020392424A1/en not_active Abandoned
- 2020-11-27 KR KR1020227017465A patent/KR20220106974A/ko active Pending
- 2020-11-27 CR CR20220305A patent/CR20220305A/es unknown
- 2020-11-27 BR BR112022010311A patent/BR112022010311A2/pt not_active IP Right Cessation
- 2020-11-27 US US17/780,064 patent/US12485119B2/en active Active
- 2020-11-27 ES ES20820054T patent/ES2994089T3/es active Active
- 2020-11-27 WO PCT/EP2020/083593 patent/WO2021105331A1/en not_active Ceased
- 2020-11-27 JP JP2022531531A patent/JP7721520B2/ja active Active
- 2020-11-27 TW TW109141697A patent/TW202133851A/zh unknown
- 2020-11-27 MX MX2022006403A patent/MX2022006403A/es unknown
- 2020-11-27 CN CN202080081138.2A patent/CN114728002A/zh active Pending
- 2020-11-27 PE PE2022000799A patent/PE20221320A1/es unknown
- 2020-11-27 JO JOP/2022/0127A patent/JOP20220127A1/ar unknown
- 2020-11-27 IL IL293271A patent/IL293271A/en unknown
- 2020-11-27 EP EP20820054.3A patent/EP4065119B1/en not_active Revoked
- 2020-11-27 PH PH1/2022/551294A patent/PH12022551294A1/en unknown
-
2022
- 2022-06-28 EC ECSENADI202251163A patent/ECSP22051163A/es unknown
-
2024
- 2024-07-24 JP JP2024118344A patent/JP7620758B2/ja active Active
-
2025
- 2025-07-30 JP JP2025127467A patent/JP2025172745A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1547464B (zh) | 缓释治疗性生物粘附系统 | |
| JP2020529996A5 (https=) | ||
| CN100594936C (zh) | 改善透粘膜给药制剂的吸收的方法 | |
| AU2023398975A1 (en) | Irak4 degraders and uses thereof | |
| De Zeeuw et al. | Pharmacokinetics of candesartan cilexetil in patients with renal or hepatic impairment. | |
| JP2023504115A5 (https=) | ||
| CN113018273A (zh) | 一种固体制剂及其制备方法和用途 | |
| JP7343478B2 (ja) | 処置の方法 | |
| JP2022031527A (ja) | ピルフェニドンの粒子の大きさ調節による打錠性が改善された薬剤学的組成物およびその製造方法 | |
| JPH0667842B2 (ja) | 基本的うつ病を軽減するためのうつ病治療剤 | |
| TWI783921B (zh) | 手部溼疹之治療 | |
| JP2025504219A5 (https=) | ||
| JP2022177119A5 (https=) | ||
| MX2013005716A (es) | Formulacion de un complejo que comprende clorhidrato de lercanidipina y valsartan y metodo para la preparacion de la misma. | |
| EP2509586B1 (en) | Mucoadhesive buccal tablets for the treatment of orofacial herpes | |
| EP4344701A1 (en) | Pharmaceutical composition comprising 1-(3-cyano-1-isopropyl-indol-5-yl)pyrazole-4-carboxylic acid | |
| EP2535048A1 (en) | Extended release preparation | |
| EP1465607B1 (fr) | Compositions pharmaceutiques a liberation modifiee | |
| WO2018028841A1 (en) | Solid pharmaceutical composition of abacavir, lamivudine, and efavirenz | |
| JP2002531495A (ja) | ウイルス疾患を処置するためのビュープロピオン | |
| CN107205987A (zh) | 根据auc进行奥美沙坦给药的方法 | |
| US20240415814A1 (en) | Pharmaceutical composition comprising 1-(3-cyano-1-isopropyl-indol-5-yl)pyrazole-4-carboxylic acid | |
| HUP0300970A2 (hu) | Epinastint és pszeudoefedrint tartalmazó új gyógyszerkészítmények | |
| JP3002766B2 (ja) | 脳浮腫治療剤 | |
| WO2018129463A1 (en) | Co-administration of minocycline and colistin to reduce acute kidney injury |